Tag archive for ‘Coronavirus’
By pharmanewsdaily On Saturday, January 23rd, 2021
0 Comments

UAE approves Russia-made Sputnik V Covid-19 vaccine

(adsbygoogle = window.adsbygoogle || []).push({}); The Russian Direct Investment Fund (RDIF) said that the Russian Sputnik V Covid-19 vaccine has been authorized for use by the UAE Ministry of Health More...

By pharmanewsdaily On Thursday, January 14th, 2021
0 Comments

Dr. Reddy’s reports success for Russian Covid-19 vaccine Sputnik V

Indian pharma company Dr. Reddy’s Laboratories announced that Sputnik V, a registered Covid-19 vaccine in Russia, has succeeded in a phase 2 trial in India by meeting the primary endpoint of safety. An independent More...

By pharmanewsdaily On Sunday, December 20th, 2020
0 Comments

Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech

Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company BioNTech. The Swiss pharma regulator said that More...

By pharmanewsdaily On Saturday, December 19th, 2020
0 Comments

Lilly to launch pragmatic study of Covid-19 drug candidate bamlanivimab in New Mexico

Eli Lilly and Company (Lilly) has revealed plans to launch a new pragmatic study of bamlanivimab (LY-CoV555) in high-risk patients with Covid-19, in partnership with major local institutions in New Mexico. The US More...

By pharmanewsdaily On Saturday, December 19th, 2020
0 Comments

US FDA authorizes Moderna Covid-19 vaccine mRNA-1273

Moderna Covid-19 vaccine : The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for mRNA-1273, the messenger RNA (mRNA) Covid-19 vaccine candidate of Moderna. The FDA authorization More...

By pharmanewsdaily On Friday, December 11th, 2020
0 Comments

Pfizer and BioNTech secure FDA EUA for BNT162b2 Covid-19 vaccine

BNT162b2 FDA EUA : Pfizer and BioNTech have been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for BNT162b2, their Covid-19 mRNA vaccine. BNT162b2 has been authorized by More...

By pharmanewsdaily On Wednesday, December 9th, 2020
0 Comments

Pfizer, BioNTech get Canadian approval for BNT162b2 Covid-19 vaccine

US pharma giant Pfizer and German biotech company BioNTech have bagged Health Canada approval for their BNT162b2 Covid-19 vaccine. The BNT162b2 vaccine has been authorized to be used in Canada under the regulator’s More...

By pharmanewsdaily On Monday, November 9th, 2020
0 Comments

BNT162b2 Covid-19 vaccine candidate more than 90% effective in phase 3 trial, say Pfizer and BioNTech

Pfizer and BioNTech announced that the BNT162b2 mRNA-based vaccine candidate has been shown to be more than 90% effective in the prevention of Covid-19 in participants of a phase 3 trial who were not previously More...

By businessnewstoday On Saturday, June 13th, 2020
0 Comments

UK pub operator Mitchells & Butlers secures £100m CLBILS loan

UK pub operator Mitchells & Butlers has been granted £100 million of additional funding from HSBC UK and Santander UK as part of the UK government’s Coronavirus Large Business Interruption Loan Scheme More...

By businessnewstoday On Wednesday, May 27th, 2020
0 Comments

COVID-19 forces Texas Capital, Independent Bank to call off $5.5bn merger

The prevailing coronavirus pandemic has forced US bank holding companies Texas Capital Bancshares and Independent Bank Group to terminate their previously announced all-stock merger of equals worth $5.5 billion. Both More...